Skip to main content
Premium Trial:

Request an Annual Quote

We'll Look Into It, But That Doesn't Mean a Thing

While the NIH has said that it may tighten financial conflicts of interest regulations, The Chronicle of Higher Education says NIH might not do anything of the sort. Sally Rockey, the NIH's acting deputy director for extramural research, tells them that the review of NIH policies could end with a decision to leave the regulations alone and adds that universities are responsible for monitoring their employees' conduct.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.